Intuitive Surgical Wins FDA Approval for Advanced Vessel Sealer Curved Device

Intuitive Surgical, Inc. (ISRG) announced that the U.S. Food & Drug Administration (FDA) has granted clearance for its Vessel Sealer Curved, marking another milestone in the company’s surgical innovation portfolio. The newly approved instrument is specifically designed for integration with the company’s da Vinci robotic surgical systems, expanding the platform’s surgical capabilities and offering surgeons enhanced precision tools for complex procedures.

Advanced Functionality for Modern Surgery

The Vessel Sealer Curved represents a specialized electrosurgical instrument engineered to perform multiple critical functions during minimally invasive procedures. The device is capable of sealing blood vessels and tissue, cutting through tissue planes, grasping anatomical structures, and dissecting tissue with controlled energy delivery. This multi-functional design reduces the need for instrument exchanges during surgery, potentially improving procedural efficiency and patient outcomes. The vessel sealer’s curved design provides surgeons with improved access to anatomical areas that are traditionally challenging to reach.

Strengthening the da Vinci Ecosystem

The FDA clearance strengthens Intuitive Surgical’s comprehensive ecosystem for robotic-assisted surgery. By adding the Vessel Sealer Curved to its growing library of specialized instruments, da Vinci systems become more versatile tools for surgical teams. This approval enables surgeons to perform a broader range of minimally invasive procedures while maintaining the precision and control that have made da Vinci the industry’s leading robotic surgical platform. The vessel sealer’s integration continues the company’s commitment to expanding treatment options across multiple surgical specialties.